What does Myriad Genetics, Inc. do?
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. It offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion…
What is Myriad Genetics, Inc.'s P/E and P/B ratio?
Myriad Genetics, Inc. has a P/E ratio of -4.9 and a P/B ratio of 1.81.
What is Myriad Genetics, Inc.'s debt-to-equity ratio?
Myriad Genetics, Inc. has a debt-to-equity ratio of 0.69.
How much does Myriad Genetics, Inc. owe compared with what it owns?
Myriad Genetics, Inc. owes $0.52 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Myriad Genetics, Inc.'s Positivity rank?
Myriad Genetics, Inc. is ranked #4,640 of 6,774 companies globally and #2,376 of 4,000 in United States on PositoAI, with a Positivity Score of 19,168.
Does Myriad Genetics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Myriad Genetics, Inc..
Where can I read the latest news about Myriad Genetics, Inc.?
Recent headlines about Myriad Genetics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Myriad Genetics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Myriad Genetics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.